Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

   
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2003

or

   
[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                            to

Commission File No. 000-50118

VistaCare, Inc.

(Exact name of registrant as specified in its charter)
     
Delaware
(State or other jurisdiction of incorporation or organization)
  06-1521534
(I.R.S. Employer Identification No.)
     
8125 North Hayden Road, Suite 300
Scottsdale, Arizona

(Address of principal executive offices)
  85258
(Zip code)

(480) 648-4545
(Registrant’s telephone number, including area code)

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. [X] Yes   [   ] No

     Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). [   ] Yes   [X] No

     As of April 15, 2003, there were outstanding 15,545,939 shares of the registrant’s Class A Common Stock, $0.01 par value per share, and 58,096 shares of the registrant’s Class B Common Stock, $0.01 par value per share.

 


TABLE OF CONTENTS

PART I — FINANCIAL INFORMATION
Item 1. Financial Statements
Condensed Consolidated Balance Sheets - March 31, 2003 and December 31, 2002
Condensed Consolidated Statements of Operations - Three months ended March 31, 2003 and 2002
Condensed Consolidated Statements of Cash Flows - Three months ended March 31, 2003 and 2002
Notes to Condensed Consolidated Financial Statements - March 31, 2003
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
PART II — OTHER INFORMATION
Item 1. Legal Proceedings
Item 2. Changes in Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Submission of Matters to a Vote of Security Holders
Item 5. Other Information
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
EXHIBIT INDEX
EX-10.39
EX-99.1
EX-99.2


Table of Contents

TABLE OF CONTENTS

         
    Page
   
PART I - FINANCIAL INFORMATION     1  
     Item 1. Financial Statements     1  
          Condensed Consolidated Balance Sheets — March 31, 2003 and December 31, 2002        
          Condensed Consolidated Statements of Operations — Three months ended March 31, 2003 and 2002        
          Condensed Consolidated Statements of Cash Flows — Three months ended March 31, 2003 and 2002        
          Notes to Condensed Consolidated financial Statements — March 31, 2003        
     Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations     13  
     Item 3. Quantitative and Qualitative Disclosures About Market Risk     30  
     Item 4. Controls and Procedures     30  
PART II - OTHER INFORMATION     31  
     Item 1. Legal Proceedings     31  
     Item 2. Changes in Securities and Use of Proceeds     31  
     Item 3. Defaults Upon Senior Securities     31  
     Item 4. Submission of Matters to a Vote of Security Holders     31  
     Item 5. Other Information     31  
     Item 6. Exhibits and Reports on Form 8-K     31  

i


Table of Contents

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

VISTACARE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

                       
          December 31   March 31
          2002   2003
         
 
                (unaudited)
          (In thousands, except
          per share information)
ASSETS                
Current assets:
               
 
Cash and cash equivalents
  $ 39,104     $ 39,511  
 
Patient accounts receivable
    19,075       20,124  
 
Patient accounts receivable room & board
    7,613       9,125  
 
Prepaid expenses and other current assets
    1,312       2,321  
 
 
   
     
 
Total current assets
    67,104       71,081  
Equipment, net
    2,612       2,835  
Goodwill, net of amortization
    20,564       20,564  
Other assets
    4,663       5,255  
 
 
   
     
 
Total assets
  $ 94,943     $ 99,735  
 
 
   
     
 
LIABILITIES AND STOCKHOLDERS’ EQUITY                
Current liabilities:
               
 
Accounts payable
  $ 2,288     $ 2,415  
 
Accrued expenses
    22,982       23,576  
 
Current portion of long-term debt
    250       250  
 
Current portion of capital lease obligations
    82       84  
 
 
   
     
 
Total current liabilities
    25,602       26,325  
Capital lease obligations, less current portion
    94       72  
Stockholders’ equity:
               
 
Class A Common Stock, $0.01 par value; authorized 33,000,000 shares; 15,420,899 and 15,545,939 shares issued and outstanding at December 31, 2002 and March 31, 2003, respectively
    154       155  
 
Class B Common Stock, $0.01 par value; authorized 200,000 shares; 58,096 shares issued and outstanding at December 31, 2002 and March 31, 2003
    1       1  
 
Additional paid-in capital
    101,161       101,216  
 
Deferred compensation
    (2,552 )     (1,341 )
 
Accumulated deficit
    (29,517 )     (26,693 )
 
 
   
     
 
Total stockholders’ equity
    69,247       73,338  
 
 
   
     
 
Total liabilities and stockholders’ equity
  $ 94,943     $ 99,735  
 
 
   
     
 

See accompanying notes to condensed consolidated financial statements.

1


Table of Contents

VISTACARE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                     
        Three Months Ended March 31
        2002   2003
       
 
        (unaudited)
        (In thousands, except per share information)
Net patient revenue
  $ 27,674     $ 42,001  
Operating expenses:
               
 
Patient care
    17,269       24,085  
 
General and administrative expenses, exclusive of stock-based compensation charges reported below
    8,911       13,352  
 
Depreciation and amortization
    272       344  
 
Stock-based compensation
    50       1,047  
 
   
     
 
   
Total operating expenses
    26,502       38,828  
 
   
     
 
Operating income
    1,172       3,173  
 
   
     
 
Non-operating (expense) income:
               
 
Interest income
    2       101  
 
Interest expense
    (201 )     (48 )
 
Other expense
    (28 )     (16 )
 
   
     
 
   
Total non-operating (expense) income
    (227 )     37  
 
   
     
 
Net income before income taxes
    945       3,210  
Income tax expense
    36       386  
 
   
     
 
Net income
    909       2,824  
Accrued preferred stock dividends
    1,032        
 
   
     
 
Net (loss) income to common stockholders
  $ (123 )   $ 2,824  
 
   
     
 
Net (loss) income per common share:
               
 
Basic net (loss) income per common share
  $ (0.02 )   $ 0.18  
 
   
     
 
 
Diluted net (loss) income per common share
  $ (0.02 )   $ 0.17  
 
   
     
 
Weighted average shares outstanding:
               
 
Basic
    5,100       15,500  
 
   
     
 
 
Diluted
    5,100       16,656  
 
   
     
 

See accompanying notes to condensed consolidated financial statements.

2


Table of Contents

VISTACARE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                     
        Three Months Ended
        March 31,
        2002   2003
       
 
        (unaudited)
        (In thousands)
Operating activities
               
Net income
  $ 909     $ 2,824  
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
               
 
Depreciation and amortization
    272       344  
 
Warrant amortization
    38        
 
Deferred compensation related to stock options
    50       1,047  
 
Changes in operating assets and liabilities:
               
   
Patient accounts receivable
    (4,605 )     (2,560 )
   
Prepaid expenses and other
    (390 )     (1,008 )
   
Accounts payable and accrued expenses
    336       700  
 
   
     
 
Net cash (used in) provided by operating activities
    (3,390 )     1,347  
Investing activities
               
Purchases of equipment
    (71 )     (425 )
Increase in other assets
    (243 )     (735 )
 
   
     
 
Net cash used in investing activities
    (314 )     (1,160 )
Financing activities
               
Net proceeds on long-term debt
    3,194        
Proceeds from issuance of common stock from exercise of stock options
          220  
 
   
     
 
Net cash provided by financing activities
    3,194       220  
 
   
     
 
Net (decrease) increase in cash and cash equivalents
    (510 )     407  
Cash and cash equivalents, beginning of period
    1,384       39,104  
 
   
     
 
Cash and cash equivalents, end of period
  $ 874     $ 39,511  
 
   
     
 

See accompanying notes to condensed consolidated financial statements.

3


Table of Contents

VISTACARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
MARCH 31, 2003
(Unaudited)

Description of Business

     VistaCare, Inc. (VistaCare), is a Delaware corporation providing medical care designed to address the physical, emotional, and spiritual needs of patients with a terminal illness and to support their family members. Hospice services are provided predominately in the patient’s home; however, certain patients require inpatient services. These inpatient services are provided by VistaCare at its stand-alone inpatient facility in Cincinnati, Ohio, at its hospital-based inpatient facility in Albuquerque, New Mexico or through leased beds at unrelated hospitals and skilled nursing facilities on a per diem basis. VistaCare provides services in Alabama, Arizona, Colorado, Georgia, Indiana, Massachusetts, New Mexico, Nevada, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas and Utah.

1.     Significant Accounting Policies

Basis of Presentation

     The accompanying condensed consolidated financial statements include accounts of VistaCare and its wholly-owned subsidiaries: VistaCare USA, Inc., Vista Hospice Care, Inc., and FHI Health Services, Inc. (including its wholly-owned subsidiaries). Intercompany transactions and balances have been eliminated in consolidation.

     The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the three month periods ended March 31, 2003 are not necessarily indicative of the results that may be expected for the year ended December 31, 2003.

     The balance sheet at December 31, 2002 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in VistaCare Inc.’s annual report on Form 10-K for the year ended December 31, 2002.

Capitalized Software Development Costs

     VistaCare capitalizes certain internal salaries related to the development of computer software used in its operations. Such capitalized software development costs are being amortized over three years. Capitalized software development costs, net of amortization, included in other assets, amounted to $3,965,000 million at December 31, 2002 and $4,273,000 million at March 31, 2003, respectively. Costs incurred during the preliminary project stage and post implementation/operations stage are expensed as incurred.

Goodwill

     During 1998, VistaCare completed the acquisitions of FHI Health Services, Inc. and Vencor Hospice, Inc. (VistaCare USA, Inc.). During 2002, VistaCare completed the acquisition of Palliative Care Concepts, Inc. The difference between the purchase prices and the fair value of assets acquired and liabilities assumed was recorded as goodwill. Prior to January 1,

4


Table of Contents

VISTACARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
MARCH 31, 2003
(Unaudited)

2002, VistaCare amortized goodwill over a period of 30 years. Amortization related to goodwill totalled $2,408,000 on January 1, 2002 and 2003. No amortization was recognized in the three months ended March 31, 2002 and 2003.

     In June 2001, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 141, Business Combinations, and SFAS No. 142, Goodwill and Other Intangible Assets, which became effective for VistaCare in the first quarter of 2002. Under these new rules, goodwill and intangible assets deemed to have indefinite lives are no longer amortized but are subject to impairment tests that must be conducted at least annually, or more often if events or circumstances arise that indicate that the carrying value of the goodwill associated with VistaCare’s acquired businesses exceeds its fair market value. VistaCare determined that no impairment of goodwill existed at December 31, 2002 or at March 31, 2003.

Acquisition

     In August 2002, VistaCare completed the acquisition of Palliative Care Concepts, Inc., a hospice program in Albuquerque, New Mexico. VistaCare paid $2,500,000 in cash and issued a $250,000 unsecured promissory note to the seller in connection with the acquisition. The purchase price was allocated primarily to goodwill.

Net Patient Revenue

     Net patient revenue is the amount VistaCare believes it is entitled to collect for its services, adjusted as described below. The amount VistaCare believes it is entitled to collect for its services varies depending on the level of care provided, the payor and the geographic area where services are rendered. Net patient revenue includes adjustments for charity care and estimated payment denials (which VistaCare experiences from time to time for reasons such as its failure to submit complete and accurate claim documentation, its failure to provide timely written physician certifications as to patient eligibility, or the payor deems the patient ineligible for insurance coverage), contractual adjustments, amounts VistaCare estimates it could be required to repay to Medicare, such as payments that VistaCare would be required to make in the event that any of its programs exceed the annual per-beneficiary cap, and subsequent changes to initial level of care determinations. VistaCare adjusts its estimates from time to time based on its billing and collection experience. VistaCare believes that it can reasonably estimate such adjustments to net patient revenue because it has significant historical experience and because it has a centralized billing and collection department that continually monitors the factors that could potentially result in a change in estimate. There were no material changes in estimates to net patient revenue for the year ended December 31, 2002 or the three-month periods ended March 31, 2002 and 2003. Vistacare recognizes net patient revenue once the patient’s hospice eligibility has been certified, the patient’s coverage from a payment source has been verified and services have been provided to that patient.

     Approximately 97% and 96% of VistaCare’s net patient revenue was derived from the Medicare and Medicaid programs for the three-month periods ended March 31, 2002 and 2003, respectively. VistaCare operates under arrangements with Medicare, Medicaid and other third-party payors pursuant to which these payors reimburse VistaCare for services it provides

5


Table of Contents

VISTACARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
MARCH 31, 2003
(Unaudited)

to hospice-eligible patients these payors cover, subject only to VistaCare’s submission of adequate and timely claim documentation. VistaCare has a patient intake process that screens patients for hospice eligibility and identifies whether their care will be covered by Medicare, Medicaid, private insurance, managed care or self-pay. Whether Medicare or Medicaid continue to provide reimbursement for hospice care is dependent upon governmental policies.

Medicare and Medicaid Regulation

     VistaCare is subject to certain limitations on Medicare payments for services. Specifically, if the number of inpatient care days of care any hospice program provides to Medicare beneficiaries exceeds 20% of the total days of hospice care such program provides to all patients for an annual period beginning September 28, the days in excess of the 20% figure may be reimbursed only at the routine home care rate. None of VistaCare’s hospice programs exceeded the payment limits on inpatient services in the three-month periods ended March 31, 2002 or 2003.

     VistaCare is also subject to a Medicare annual per-beneficiary cap. Compliance with the Medicare per-beneficiary cap is measured by comparing the cost of services provided to each Medicare beneficiary by each hospice program during the Medicare fiscal year ending October 31 to the per-beneficiary cap amount for each Medicare beneficiary in such program who elects to receive the Medicare hospice benefit for the first time during such fiscal year. VistaCare recorded reductions to net patient revenue of approximately $399,000 for the three months ended March 31, 2003, respectively, as estimates for exceeding the Medicare per-beneficiary cap. VistaCare did not record any reduction to net patient revenue for the three months ended March 31, 2002 as an estimate for exceeding the per-beneficiary cap in that period. As of the date of this report, VistaCare had not been assessed any amounts for exceeding the per-beneficiary cap for the assessment periods that began on November 1, 2001 and November 1, 2002. VistaCare management believes that as of March 31, 2003 adequate reserves have been established for this potential liability.

     VistaCare monitors each of its programs to determine whether such programs are likely to exceed the foregoing limitations and estimates the extent to which it could be required to repay Medicare. At the time that management estimates the potential impact of having exceeded the Medicare limitations, the estimated assessment is deducted from net patient revenue and accrued as an accrued expense until such time as an actual payment is assessed by Medicare.

     Laws and regulations governing the Medicare and Medicaid program are complex and subject to interpretation. VistaCare believes that it is in compliance with all applicable laws and regulations and is not aware of any pending or threatened investigations involving allegations of potential wrongdoing which would have a material impact on VistaCare’s consolidated financial condition or results of operations. Compliance with such laws and regulations can be subject to future government review and interpretation as well as significant regulatory action including fines, penalties, and exclusion from the Medicare and Medicaid programs.

Charity Care

     VistaCare provides care at no cost to patients who are not eligible for insurance coverage and meet certain financial need criteria established by VistaCare. Charity care totaled approximately $513,000 and $666,000 for the three months ended March 31, 2002 and 2003, respectively. Because VistaCare does not pursue collection of amounts determined to qualify as charity care, these amounts are not recorded in net patient revenue. Costs VistaCare incurs in providing charity care are recorded as patient care expenses.

6


Table of Contents

VISTACARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
MARCH 31, 2003
(Unaudited)

Nursing Home Costs

     For patients receiving nursing home care under state Medicaid programs who elect hospice care under Medicare or Medicaid, VistaCare contracts with nursing homes for the nursing homes’ provision to patients of room and board services. In most states, the applicable Medicaid program must pay VistaCare, in addition to the applicable Medicare or Medicaid hospice daily or hourly rate, an amount equal to at least 95% of the Medicaid daily nursing home rate for room and board furnished to the patient by the nursing home. In some states, the Medicaid program pays the nursing home directly for these costs or has created a Medicare managed care program that either reduces or eliminates this room and board payment. Under VistaCare’s standard nursing home contracts, VistaCare pays the nursing home for these room and board services at predetermined contract rates. Nursing home costs are offset by nursing home revenue and the net amount is included in patient care expenses.

     Nursing home costs totaled approximately $3,700,000 and $7,500,000 for the three months ended March 31, 2002 and 2003, respectively. Nursing home revenue totaled approximately $3,500,000 and $7,100,000 for the three months ended March 31, 2002 and 2003, respectively.

Income Taxes

     VistaCare accounts for income taxes under the liability method as required by SFAS No. 109, Accounting for Income Taxes. Under the liability method, deferred taxes are determined based on temporary differences between financial statement and tax bases of assets and liabilities existing at each balance sheet date using enacted tax rates for years in which the related taxes are expected to be paid or recovered. Valuation allowances are established against the deferred tax assets due to the uncertainty of VistaCare’s ability to use net operating tax loss carryforwards in the future.

Medical Malpractice

     VistaCare is covered by claims-made general and professional liability insurance coverage with limits of $1,000,000 per claim and $3,000,000 in the aggregate. VistaCare has not experienced any uninsured medical malpractice losses.

Use of Estimates

     The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

7


Table of Contents

VISTACARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
MARCH 31, 2003
(Unaudited)

Stock-Based Compensation

     VistaCare has elected to follow Accounting Principles Board Opinion No. 25 (APB No. 25), Accounting for Stock Issued to Employees and related interpretations, in accounting for its employee stock options rather than the alternative fair value accounting allowed by SFAS No. 123 (SFAS 123), Accounting for Stock-Based Compensation. Under APB No. 25, if the exercise price of VistaCare’s stock options equals or exceeds the estimated fair value of the underlying stock on the dates of grant, no compensation expense is recognized. However, if the exercise prices of VistaCare’s stock options are less than the estimated fair value, on the date of grant, then compensation expense will be recognized for the difference over the related vesting periods.

     If compensation for options granted under VistaCare’s stock option plan had been determined based on the deemed fair value at the grant date consistent with the method provided under SFAS 123, then VistaCare’s net (loss) income would have been as indicated in the pro forma table below (in thousands, except per share information).

                   
      Three Months Ended
      March 31
      2002   2003
     
 
Net (loss) income to common stockholders:
               
 
As reported:
  $ (123 )   $ 2,824  
 
Add: Stock-based employee
compensation expense included
in reported net income, net
of related tax effects
    50       1,047  
 
Deduct: Total stock-based compensation expense determined under fair value method for all awards
    (75 )     (787 )
 
 
   
     
 
 
Pro forma net (loss) income to common stockholders
  $ (148 )   $ 3,084  
 
 
   
     
 
Basic net (loss) per common share:
               
 
As reported
  $ (0.02 )   $ 0.18  
 
Pro forma
    (0.03 )     0.20  
Diluted net (loss) per common share:
               
 
As reported
  $ (0.02 )   $ 0.17  
 
Pro forma
    (0.03 )     0.19  
Weighted average shares used in computation:
               
 
Basic
    5,100       15,500  
 
Diluted
    5,100       16,656  

Initial Public Offering

     On December 23, 2002, VistaCare completed its initial public offering of common stock (IPO) at $12.00 per share. VistaCare sold 4,500,000 shares and received $48,145,000 in net proceeds from the IPO. The remaining proceeds will be used to finance potential acquisitions of hospices and for other corporate purposes. Upon the closing of the IPO in December 2002, all of VistaCare’s redeemable and convertible preferred stock was converted into 5,603,111 shares of VistaCare’s Class A common stock. The accumulated dividends on VistaCare’s Series B, C and D preferred stock of $16,486,000, which were not payable in the event of a mandatory conversion, were reclassified as additional paid-in-capital and no additional dividends will be accrued or recorded subsequent to the IPO.

Earnings Per Share

     Basic net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares outstanding during the period. Diluted net income per common share is computed by dividing net income by the weighted average number of shares outstanding during the period plus the effect of dilutive securities, including outstanding warrants, employee stock options (using the treasury stock method) and shares of Series A-1 Preferred Stock (using the if-converted method).

8


Table of Contents

VISTACARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
MARCH 31, 2003
(Unaudited)

Recent Accounting Pronouncements

     In April 2002, the FASB issued SFAS No. 145, Rescission of FASB Statements No. 4, 44 and 64, Amendment of FASB Statement No. 13 and Technical Corrections. SFAS No. 145 is effective for fiscal years beginning after May 15, 2002. This statement eliminates accounting treatment for reporting gains or losses on debt extinguishments and amends certain other existing accounting pronouncements. The adoption of this standard is not expected to have a material effect on VistaCare’s consolidated financial position or results of operations.

     In June 2002, the FASB issued SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities. SFAS No. 146 nullifies the guidance in EITF Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity. Under EITF No. 94-3, an entity recognizes a liability for an exit cost on the date that the entity committed itself to an exit plan. In SFAS No. 146, the FASB acknowledges that an entity’s commitment to a plan does not, by itself, create a present obligation to the other parties that meets the definition of a liability and requires that a liability for a cost that is associated with an exit or disposal activities be recognized when the liability is incurred. It also establishes that fair value is the objective for the initial measurement of the liability. SFAS No. 146 will be effective for exit or disposal activity that are initiated after December 31, 2002. The adoption of this standard is not expected to have a material effect on VistaCare’s financial position or results of operations.

     In November 2002, the FASB issued Interpretation No. 45, Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others. FIN No. 45 requires certain guarantees to be recorded at fair value. FIN No. 45 also requires a guarantor to make certain disclosures about guarantees even when the likelihood of making any payments under the guarantee is remote. FIN No. 45 is effective for financial statements of interim or annual periods ending after December 15, 2002. The adoption of this interpretation did not have a material effect on VistaCare’s consolidated financial position or results of operations.

     In December 2002, the FASB issued SFAS No. 148, Accounting for Stock-Based Compensation — Transition and Disclosure. SFAS No. 148 amends SFAS No. 123, Accounting for Stock-Based Compensation and provides alternative methods of transition for a voluntarily change to the fair value based method of accounting for stock-based employee compensation. SFAS No. 148 also amends the disclosure requirements of SFAS No. 123 to require prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based compensation and the effect of the method used on reported results. SFAS No. 148 is effective for fiscal years ending after December 15, 2002. While SFAS No. 148 does not amend SFAS No. 123 to require companies to account for employee stock options using the fair value method, the disclosure provisions of SFAS No. 148 are applicable to all companies with stock-based employee compensation, regardless of whether they account for that compensation using the fair value method of SFAS No. 123 or the intrinsic method of APB Opinion No. 25. As allowed by SFAS No. 123, VistaCare has elected to continue to utilize the accounting method prescribed by APB Opinion No. 25 and has adopted the disclosure requirements of SFAS No. 123 as of December 1, 2002.

     In January 2003, the FASB issued Interpretation No. 46, Consolidation of Variable Interest Entities. FIN No. 46 addresses the consolidation and financial reporting of variable interest entities. FIN No. 46 is effective for financial statements of interim or annual periods beginning after June 15, 2002 for variable interest entities created before February 1, 2003, or immediately for variable interest entities created after February 1, 2003. The adoption of this interpretation is not expected to have a material effect on VistaCare’s consolidated financial position or results of operations.

9


Table of Contents

VISTACARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
MARCH 31, 2003
(Unaudited)

2. Accrued Expenses

     A summary of accrued expenses follows (in thousands):

                 
    December 31, 2002   March 31, 2003
   
 
Treatment costs
  $ 10,758     $ 10,530  
Self-insured health costs
    1,994       2,508  
Salaries and payroll taxes
    5,119       4,808  
Medicare cap accrual
    1,263       1,662  
Other
    3,848       4,068  
 
   
     
 
 
  $ 22,982     $ 23,576  
 
   
     
 

3. Income Taxes

     VistaCare’s provisions for income taxes for the three-month periods ended March 31, 2002 and March 31, 2003 reflect its estimates of the effective tax rate VistaCare expected to be applicable for the full year. This estimate is re-evaluated by management each quarter based upon forecasts of income before taxes for the year. VistaCare’s effective tax rate in these periods was lower than the federal statutory rates primarily due to its use of tax credits and net operating loss carryforwards.

4. Long-Term Debt

     In April 2001, VistaCare entered into a $30,000,000 revolving line of credit and a $3,000,000 term loan (credit facility). The credit facility is collateralized by substantially all of VistaCare’s assets including cash, accounts receivable and equipment. Loans under the revolving line of credit bear interest at an annual rate equal to, at VistaCare’s option, either the “prime rate” in effect from time to time, as reported in the “Money Rates” section of the Wall Street Journal, plus 1.5%, or the one-month London Interbank Borrowing Rate in effect from time to time, plus 3.0%. Accrued interest under the revolving line of credit is due (i) weekly, if VistaCare opts to pay interest at the prime rate, or (ii) on the last business day of the month, if VistaCare opts to pay interest at the London Interbank Borrowing Rate based rate.

     Under the revolving line of credit, VistaCare may borrow, repay and reborrow an amount equal to the lesser of: (i) $30,000,000 or (ii) 85% of the estimated net value of eligible accounts receivable. As of March 31, 2003, approximately $19,002,000 was available for borrowing under the revolving line of credit. The maturity date of the revolving line of credit is April 30, 2005. As of March 31, 2003, there was no balance outstanding on the revolving line of credit.

     The credit facility contains certain customary covenants including those that restrict the ability of VistaCare to incur additional indebtedness, pay dividends under certain circumstances, permit liens on property or assets, make capital expenditures, make certain investments, and prepay or redeem debt or amend certain agreements relating to outstanding indebtedness.

     In connection with its acquisition of Palliative Care Concepts, Inc., VistaCare issued a $250,000 unsecured promissory note. The promissory note bears interest at a rate of 4.0% per annum and is payable in full in August 2003.

10


Table of Contents

VISTACARE, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - (Continued)
MARCH 31, 2003
(Unaudited)

5. Dilutive Securities

     The following table presents the calculation of basic and diluted net (loss) income per common share (in thousands, except per share information):

                     
        Three Months End
        March 31
       
        2002   2003
       
 
Numerator
               
 
Net (loss) income
  $ 909     $ 2,824  
 
Series B, C and D
               
   
Preferred Stock Dividends
    (1,032 )      
 
 
   
     
 
Numerator for basic and diluted earnings per share — (loss) income available to common stockholders
  $ (123 )     2,824  
 
 
   
     
 
Denominator
           </